In the last year, Mexico has approved the Madrid Protocol, agreed to sign the Anti-Counterfeiting Trade Agreement (ACTA), introduced new data privacy laws and implemented guidelines on comparative advertising - to name just a few major IP changes. In addition, the country recently elected a new president, which means the head of the Mexican Patent and Trademark Office (IMPI) will change, and there may be new approaches by the government on many issues that affect IP
Gilda González Carmona is director general of AMPROFON, which represents Mexican record companies, and president of the Coalition for Legal Access to Culture, which is helping to draft legislation to update the country’s copyright law. Eileen McDermott spoke with her about the project, and why it is crucial to Mexico’s creative industries
After six failed attempts, Mexico has completed its journey to successful protection of privacy, say Rosa María Franco and Juan Carlos Hernandez of Basham Ringe y Correa
How to apply for a utility model in Mexico. By Heriberto López of Becerril Coca & Becerril
Laura Collada of Dumont considers the critical need for an effective opposition system as Mexico readies itself to accede to the Madrid Protocol
Enrique Diaz and Dhania Portilla of Goodrich Riquelme y Asociados explain potential problems with the practicality and rigour of Mexico’s new guidelines on comparative advertising
IP owners looking to protect industrial designs in Mexico will be confronted with a messy mix of patent and copyright law. Luis Schmidt of Olivares explains
Sergio Silva of Silva and Associates discusses to what extent Mexico’s imminent adherence to the Madrid Protocol is advantageous for the country’s IP owners and economy
Despite a special mechanism in Mexican law to protect serial publications, Carlos Trujillo of Uhthoff Gomez Vega & Uhthoff asks whether using copyright and trade mark rights might be more effective
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International